ICD-10-CM 2027 diagnosis code
E09.35Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy
E09.35 is a header code, so it can't be reported by itself. Choose one of the 6 more specific codes beneath it and add the required 7th character.Short description: Drug/chem diabetes w proliferative diabetic retinopathy
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About E09.35
E09.35 is the ICD-10-CM diagnosis code for drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy. It belongs to category E09 (drug or chemical induced diabetes mellitus), block E08-E13 (diabetes mellitus) and chapter 4 (endocrine, nutritional and metabolic diseases). It is a header code, so it can't be reported by itself; one of its 6 subcodes must be used instead.
Within E09.3 (drug or chemical induced diabetes mellitus with ophthalmic complications), E09.35 is specifically for drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy. Related codes cover unspecified diabetic retinopathy (E09.31), mild nonproliferative diabetic retinopathy (E09.32), moderate nonproliferative diabetic retinopathy (E09.33), severe nonproliferative diabetic retinopathy (E09.34), diabetic cataract (E09.36), diabetic macular edema, resolved following treatment (E09.37) and other diabetic ophthalmic complication (E09.39).
Codes in this range require a 7th character: 1 for right eye, 2 for left eye, 3 for bilateral and 9 for unspecified eye. Use placeholder "X" characters to fill any empty positions before the 7th character.
Code first: poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4).
Use an additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5). Use an additional code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85), insulin (Z79.4), oral antidiabetic drugs (Z79.84) and oral hypoglycemic drugs (Z79.84).
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
7th character
One of the following 7th characters is to be assigned to codes in subcategory E09.35 to designate laterality of the disease:
- E09.351Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema
- E09.352Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula
- E09.353Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula
- E09.354Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment
- E09.355Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy
- E09.359Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema
- 1right eye
- 2left eye
- 3bilateral
- 9unspecified eye
Notes that apply from higher levels
Instructions written at a parent level also apply to E09.35.
› From E09 Drug or chemical induced diabetes mellitus
- diabetes mellitus due to underlying condition (E08.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- postpancreatectomy diabetes mellitus (E13.-)
- postprocedural diabetes mellitus (E13.-)
- secondary diabetes mellitus NEC (E13.-)
- type 1 diabetes mellitus (E10.-)
- type 2 diabetes mellitus (E11.-)
Broader instructions also apply from Chapter 4: Endocrine, nutritional and metabolic diseases.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about E09.35
Is E09.35 billable?
- No. E09.35 is a header code. Report one of its more specific subcodes instead.